BofA Securities initiated coverage on U.S. Physical Therapy with a new price target
$USPH
Medical/Nursing Services
Health Care
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2026 | $103.00 → $90.00 | Outperform | Barrington Research |
| 3/10/2026 | $102.00 | Buy | Jefferies |
| 9/18/2025 | $110.00 | Overweight | Analyst |
| 12/16/2024 | $100.00 → $115.00 | Neutral → Buy | BofA Securities |
| 12/16/2024 | $113.00 | Mkt Outperform | JMP Securities |
| 10/7/2024 | $114.00 → $90.00 | Buy → Neutral | BofA Securities |
| 9/22/2023 | $108.00 | Overweight | JP Morgan |
| 6/30/2023 | $138.00 | Buy | BofA Securities |
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
U.S. Physical Therapy, Inc. (the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, Chairman and Chief Executive Officer, presented at the BofA Securities 2026 Healthcare Conference held on May 13, 2026. The presentation included a discussion of the overall operating environment in healthcare, the Company's key initiatives and a broad overview of opportunities. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 784 outpatient physical therapy clinics in 44 states. USPH clinics provide preventative and post
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), today reported results for the first quarter ended March 31, 2026 ("Q1 2026"). Total net revenue of $198.3 million for Q1 2026, a 7.9% increase over the first quarter ended March 31, 2025 ("Q1 2025"). Net income attributable to USPH shareholders of $5.0 million for Q1 2026, compared to $9.9 million for Q1 2025. Included in pretax income for Q1 2026 was a loss on change in fair value of contingent earn out consideration of $2.0 million versus a gain of $4.8 million in Q1 2025. Under GAAP
PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
10-Q - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
Barrington Research reiterated coverage of U.S. Physical Therapy with a rating of Outperform and set a new price target of $90.00 from $103.00 previously
Jefferies resumed coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $102.00
Analyst resumed coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $110.00
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
PACS Group, Inc. (NYSE:PACS), one of the nation's largest and fastest-growing post-acute healthcare platforms, today announced the appointment of Carey P. Hendrickson as its Chief Financial Officer, effective April 27, 2026. Mr. Hendrickson brings to PACS nearly four decades of financial leadership spanning public company CFO roles in healthcare, senior living, and media — a body of work distinguished by financial discipline, strategic acuity, and a consistent record of building high-performing teams that drive measurable results. His appointment marks a significant milestone for PACS as the company continues to scale its national footprint and deepen its clinical and operational leadership
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services headquartered in Houston, Texas, today announced a dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas, Texas. U.S. Physical Therapy will maintain its primary listing on the New York Stock Exchange and trade with the same "USPH" ticker symbol on NYSE Texas. Chris Reading, Chairman and Chief Executive Officer, said, "We are honored to join NYSE Texas as a Founding Member and to champion the dynamic growth, energy and grit that define this great state. Being
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services ("IIP"), today reported results for the first quarter ended March 31, 2026 ("Q1 2026"). Total net revenue of $198.3 million for Q1 2026, a 7.9% increase over the first quarter ended March 31, 2025 ("Q1 2025"). Net income attributable to USPH shareholders of $5.0 million for Q1 2026, compared to $9.9 million for Q1 2025. Included in pretax income for Q1 2026 was a loss on change in fair value of contingent earn out consideration of $2.0 million versus a gain of $4.8 million in Q1 2025. Under GAAP
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the first quarter ended March 31, 2026, on Wednesday, May 6, 2026, after the stock market closes, with the conference call to follow the next morning, on Thursday, May 7, 2026. Conference Call Date: Thursday, May 7, 2026 Time: 10:30 am Eastern / 9:30 am Central Dial-In Number (800) 445-7795 Primary or (785) 424-1699 Alternate Conference ID:
U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the fourth quarter and full year ended December 31, 2025. FINANCIAL HIGHLIGHTS Year Ended December 31, 2025 versus Year Ended December 31, 2024 Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $95.0 million for the year ended December 31, 2025 ("2025 Year"), an increase of $13.2 million or 16.2%, from $81.8 million for the year ended December 31, 2024 ("2024 Year"). Net income attributable to USPH shareholders ("USPH Net In
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)